Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daria Piątkowska

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|July 11, 2025
The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategiesWiktoria Strasenburg, Jędrzej Borowczak, Daria Piątkowska, et al.
Cancers|March 13, 2024
Ubiquitin B, Ubiquitin C, and β-Catenin as Promising Diagnostic and Prognostic Tools in Prostate CancerDaria Piątkowska, Anna Klimaszewska-Wiśniewska, Alicja Kosińska, et al.
Biomedicines|September 27, 2025
The Prognostic Role of IL-6 and RBP4 in Colorectal CancerMałgorzata Żulicka, Daria Piątkowska, Dariusz Grzanka, et al.
The Journal of Pathology. Clinical Research|March 4, 2024
Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinomaMartyna Parol-Kulczyk, Justyna Durślewicz, Laura Blonkowska, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|July 11, 2025
The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategiesWiktoria Strasenburg, Jędrzej Borowczak, Daria Piątkowska, et al.
Cancers|March 13, 2024
Ubiquitin B, Ubiquitin C, and β-Catenin as Promising Diagnostic and Prognostic Tools in Prostate CancerDaria Piątkowska, Anna Klimaszewska-Wiśniewska, Alicja Kosińska, et al.
Biomedicines|September 27, 2025
The Prognostic Role of IL-6 and RBP4 in Colorectal CancerMałgorzata Żulicka, Daria Piątkowska, Dariusz Grzanka, et al.
The Journal of Pathology. Clinical Research|March 4, 2024
Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinomaMartyna Parol-Kulczyk, Justyna Durślewicz, Laura Blonkowska, et al.
Pageof 1